Cytokinetics Inc. buy Morgan Stanley
Start price
13.02.25
/
50%
€41.00
Target price
13.02.26
€64.45
Performance (%)
35.37%
End price
14.02.26
€55.50
Summary
This prediction ended on 14.02.26 with a price of €55.50. With a performance of 35.37% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | -2.703% | -2.703% | 31.068% |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% |
Comments by Morgan_Stanley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $67.00 price target on the stock, down previously from $70.00.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Cytokinetics Inc.
Stopped prediction by Morgan_Stanley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.20
04.08.23
04.08.23
€54.39
04.08.24
04.08.24
67.22%
05.08.24
05.08.24
